China Universal Asset Management Co., Ltd.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1906594 SHANGHAI, F4

Position in ACRS

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$117,586

+$37,333 QoQ

Shares Held

22,228

+3.9% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#93

of 149 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $181,209,200 across 241 Biotechnology names. ACRS ranks #157 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$117,586	22,228	+3.9%	Shares	Sole	2026-07-24
2026-03-31	$80,253	21,401	+21.2%	Shares	Sole	2026-04-28
2025-12-31	$53,141	17,655	+28.7%	Shares	Sole	2026-01-29
2024-09-30	$15,780	13,722	+63.9%	Shares	Sole	2024-10-25
2024-06-30	$9,209	8,372	-38.6%	Shares	Sole	2024-07-19
2024-03-31	$16,897	13,627	+66.3%	Shares	Sole	2024-05-21
2023-12-31	$8,605	8,196	+351.8%	Shares	Sole	2024-05-22
2023-09-30	$12,425	1,814	+95.9%	Shares	Sole	2024-05-22
2023-06-30	$9,602	926	+2.5%	Shares	Sole	2024-05-22
2023-03-31	$7,305	903	+33.2%	Shares	Sole	2023-04-28
2022-12-31	$10,678	678	+8.7%	Shares	Sole	2023-01-31
2022-09-30	$9,821	624	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.